1197 MK-5172 IN COMBINATION WITH PEG-INTERFERON/RIBAVIRIN DEMONSTRATES ROBUST EFFICACY AND A LOW RATE OF RESISTANCE-ASSOCIATED VIROLOGIC FAILURE IN TREATMENT NAÏVE GENOTYPE 1 CHRONIC HCV-INFECTED PATIENTS